KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Outstanding
Ratios

CRISPR Therapeutics AG (CRSP) R&D In Process (2025)

Historic R&D In Process for CRISPR Therapeutics AG (CRSP) over the last 1 years, with Q2 2025 value amounting to $96.3 million.

  • CRISPR Therapeutics AG's R&D In Process changed N/A to $96.3 million in Q2 2025 from the same period last year, while for Dec 2025 it was $96.3 million, marking a year-over-year change of. This contributed to the annual value of $96.3 million for FY2025, which is N/A changed from last year.
  • Per CRISPR Therapeutics AG's latest filing, its R&D In Process stood at $96.3 million for Q2 2025.
  • Over the past 5 years, CRISPR Therapeutics AG's R&D In Process peaked at $96.3 million during Q2 2025, and registered a low of $96.3 million during Q2 2025.